OpGen Appoints Albert Weber as Chief Financial Officer

Albert Weber to join OpGen as OpGen’s CFO effective January 1, 2022 from U.S.-German molecular diagnostics company Epigenomics Announces inducement grant of 210,000 stock options under NASDAQ Listing Rule 5635(c)(4)

Related Keywords

Rockville ,Maryland ,United States ,Germany ,Holzgerlingen ,Baden Wüberg ,Frankfurt ,Brandenburg ,China ,Austria ,Chinese ,American ,Matthew Bretzius ,Oliver Schacht ,Albert Weber ,Curetis Gmb ,Company Curetis Gmb ,University Of Cologne ,Opgen Press Contact ,Maxwell Colbert Edison Group ,Technology Platform ,Opgen Inc ,Frankfurt Stock Exchange ,Masters In Business Administration Diplom Kaufmann ,Nasdaq ,Exchange Commission ,Securities Exchange ,Gene Panel ,Epigenomics Announces ,Chief Financial Officer ,Managing Director ,Curetis Gmbh ,Executive Officer ,Executive Board ,Corporate Controller ,Business Administration ,Diplom Kaufmann ,Nasdaq Listing Rule ,Ares Genetics Gmbh ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Oliver Schacht President ,Gen Press Contact ,Fischtank Marketing ,Gen Investor Contact ,Maxwell Colbert Edison ,Money ,Ational ,